To describe demographics, clinical features, and treatment outcomes of patients with highly drug-resistant tuberculosis (TB) in Ukraine, and to evaluate risk factors for an unsuccessful outcome. Data from patients with multi-, preextensively, or extensively drug-resistant TB were collected prospectively from TB dispensaries in 15 out of 24 Ukrainian oblasts (regions) from 2020 to 2021. Treatment outcomes were evaluated using WHO definitions. Risk factors for an nsuccessful outcome were identified using a multivariable logistic regression model.
Dudnyk, A; Tytarenko, N; Romero Andrada, I; Lytvyniuk, O(American Journal of Respiratory and Critical Care Medicine, 2025)
High burden of multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB) combined with ongoing war remain the main challenges to control TB in Ukraine. In 2023, Ukraine reported 2944 MDR/RR-TB cases - in 2.7 times (1108) ...
Ukraine remains a high World Health Organization priority country for drug-resistant tuberculosis (TB). Rifampicin-resistant TB (RR-TB) has a more protracted, more complicated, and more expensive treatment. In 2021, Ukraine ...
Białoszycka, Żanna; Białoszycka, Monika; Pachevska, Alisa(Journal of Education, Health and Sport, 2025-04-07)
Introduction. In recent years, there has been a marked increase in the prevalence of cutaneous tuberculosis in Ukraine. Tuberculous lesions of the skin, as a rule, are secondary.
Case description. Tuberculous lesions of ...